131 related articles for article (PubMed ID: 2083684)
1. Role and regulation of metalloproteinases in connective tissue turnover.
Murphy G; Hembry RM; Hughes CE; Fosang AJ; Hardingham TE
Biochem Soc Trans; 1990 Oct; 18(5):812-5. PubMed ID: 2083684
[No Abstract] [Full Text] [Related]
2. [Basic metalloproteinases of the connective tissue matrix].
Solov'eva NI
Bioorg Khim; 1994 Feb; 20(2):143-52. PubMed ID: 8155077
[TBL] [Abstract][Full Text] [Related]
3. The role of plasminogen activators in the regulation of connective tissue metalloproteinases.
Murphy G; Atkinson S; Ward R; Gavrilovic J; Reynolds JJ
Ann N Y Acad Sci; 1992 Dec; 667():1-12. PubMed ID: 1339240
[No Abstract] [Full Text] [Related]
4. Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
Cawston TE
Pharmacol Ther; 1996; 70(3):163-82. PubMed ID: 8888065
[TBL] [Abstract][Full Text] [Related]
5. A matrix metalloproteinase proenzyme activator produced by articular cartilage.
Towle CA; Wright M; Hecht AC; Kuong SJ; Papanicolas LE; Totkovic R; Mankin HJ; Treadwell BV
Biochem Biophys Res Commun; 1998 Jun; 247(2):324-31. PubMed ID: 9642125
[TBL] [Abstract][Full Text] [Related]
6. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
[TBL] [Abstract][Full Text] [Related]
7. The regulation of connective tissue metalloproteinases by natural inhibitors.
Murphy G
Agents Actions Suppl; 1991; 35():69-76. PubMed ID: 1781423
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
9. Relationship of procollagenase activator, stromelysin and matrix metalloproteinase 3.
Murphy G; Nagase H; Brinckerhoff CE
Coll Relat Res; 1988 Jul; 8(4):389-91. PubMed ID: 2850888
[No Abstract] [Full Text] [Related]
10. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
[TBL] [Abstract][Full Text] [Related]
11. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
Nagase H; Suzuki K; Enghild JJ; Salvesen G
Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284
[TBL] [Abstract][Full Text] [Related]
12. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.
Takagi M; Santavirta S; Ida H; Ishii M; Mandelin J; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):35-45. PubMed ID: 9678031
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
15. The structure of aggrecan and its turnover in cartilage.
Hardingham TE; Fosang AJ
J Rheumatol Suppl; 1995 Feb; 43():86-90. PubMed ID: 7752148
[TBL] [Abstract][Full Text] [Related]
16. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
17. Unique expression patterns of matrix metalloproteinases in regenerating newt limbs.
Kato T; Miyazaki K; Shimizu-Nishikawa K; Koshiba K; Obara M; Mishima HK; Yoshizato K
Dev Dyn; 2003 Feb; 226(2):366-76. PubMed ID: 12557215
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF
FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
[TBL] [Abstract][Full Text] [Related]
19. Regulation of matrix metalloproteinases during extracellular matrix turnover.
Corcoran ML; Kleiner DE; Stetler-Stevenson WG
Adv Exp Med Biol; 1995; 385():151-9; discussion 179-84. PubMed ID: 8571826
[No Abstract] [Full Text] [Related]
20. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan.
Kuno K; Okada Y; Kawashima H; Nakamura H; Miyasaka M; Ohno H; Matsushima K
FEBS Lett; 2000 Aug; 478(3):241-5. PubMed ID: 10930576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
